AHSCT

常见例句

The preliminary result suggested that AHSCT could prolong the disease - free survival for AL, HD and ALC.
初步結果提示AHSCT能延長AL、HD和ALC患者的無病存活期。
Autologous hematopoietic stem cell transplantation(AHSCT)
自躰造血乾細胞移植
5 AL and 1 HD were still in continuous complete remission to 450, 313, 276, 112, 81 and 171 days after AHSCT respectively, intracrania1 metastases relapsed in ALC after 1l5 days of complete remission.
5例AL和1例HD已分別持續完全緩解450天、313天、276天、112天、81天和171天； 1例則ALC患者在移植後完全緩解115天後出現顱內複發。